2009-11-10 02:03:02 - Medarex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/medarex,-inc ..

Medarex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Medarex, Inc. (Medarex) is a biopharmaceutical company focused on the development and commercialization of human antibody based therapeutics for oncology, inflammation, autoimmune disorders and infectious diseases. It develops a broad range of fully human antibody product candidates with its UltiMAb and ADC technologies. Its major product candidates include Zalutumumab (HuMax-EGFR), Ipilimumab, MDX-066, MDX-1388, MEDI-545, MEDI-546 and MDX-1100. The company is headquatered in Princeton, the US

The Medarex, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines

 

 

and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.